Johnson & Johnson (NYSE:JNJ) has analysts on the Bullish side this week


Bnp Paribas Investment Partners Sa who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $354.43B market cap company. The stock declined 0.48% or $0.63 reaching $131.6 per share. About 377,946 shares traded. It has underperformed by 4.16% the S&P500. It also reduced its holding in Watts Water Technologies Inc (NYSE:WTS) by 12,000 shares in the quarter, leaving it with 102,244 shares, and cut its stake in Wright Medical Group N.V. Ltd. now owns 4,946,229 shares of the company's stock worth $569,967,000 after buying an additional 4,549,711 shares during the last quarter. The company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.77 by $0.06. The firm has a market cap of $355.21 billion, a P/E ratio of 22.17 and a beta of 0.78. The stock rose 0.77% or $1.13 reaching $148.9. About 1.91M shares traded. SeaWorld Entertainment Inc (SEAS) has risen 3.38% since July 14, 2016 and is uptrending. It has outperformed by 2.04% the S&P500. Eleven analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Therefore 80% are positive.

For a profitability analysis, According to the past 5 years report, the company on average reported -4.12% year-over-year EPS growth. Goldman Sachs upgraded Johnson & Johnson (NYSE:JNJ) on Monday, March 14 to "Neutral" rating. BMO Capital Markets reiterated a "buy" rating and issued a $132.00 price objective on shares of Johnson & Johnson in a report on Friday, June 2nd.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings data on Tuesday, April 18th. The company was initiated on Tuesday, September 22 by UBS. The firm earned "Equal-Weight" rating on Tuesday, November 29 by Barclays Capital. The rating was maintained by Piper Jaffray on Wednesday, April 27 with "Overweight". As per Tuesday, March 15, the company rating was maintained by Jefferies. Now Johnson & Johnson's current price is $11.14 shy of the official highest sell-side analyst price target on Wall Street. Cowen & Co maintained it with "Buy" rating and $14300 target in Tuesday, June 13 report. The rating was upgraded by Argus Research to "Buy" on Wednesday, July 20. L P increased its position in shares of Johnson & Johnson by 396.7% in the fourth quarter. RBC Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Wednesday, July 20.

More notable recent Prologis Inc (NYSE:PLD) news were published by: which released: "Prologis (PLD) to Post Q2 Earnings: Is a Surprise in Store?" on July 13, 2017, also with their article: "Swedbank Buys Applied Materials Inc, Prologis Inc, Pioneer Natural Resources ..." published on July 12, 2017, published: "Swedbank Buys Applied Materials Inc, Prologis Inc, Pioneer Natural Resources ..." on July 12, 2017. Leading up to this report, we have seen a -0.12% fall in the stock price over the last 30 days and a 5.15% increase over the past 3 months. Its down 0.03, from 0.82 in 2016Q3.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Robert Wood Johnson Foundation holds 13.00M shares or 98.73% of its portfolio. 359,324 are held by First Tru Advsr Lp. Mercer Advisers accumulated 76,290 shares. FBR Capital maintained the shares of MTZ in report on Tuesday, September 1 with "Outperform" rating. 43,424 are owned by Regent Management Ltd Liability Company. Raymond James And owns 414,270 shares. Brave Asset Incorporated has invested 1.64% of its portfolio in Johnson & Johnson (NYSE:JNJ).

More news: Rapper DMX charged with tax evasion: US Attorney's Office

Connable Office has invested 0.81% in Johnson & Johnson (NYSE:JNJ). Opus Management holds 54,800 shares. Crawford Counsel has invested 2.51% in Johnson & Johnson (NYSE:JNJ). 509.26 million shares or 1.75% less from 518.36 million shares in 2016Q3 were reported. Coho Partners Ltd. now owns 529,138 shares of the company's stock valued at $60,962,000 after buying an additional 3,201 shares in the last quarter. Glenview Comml Bank Dept holds 71,101 shares or 4.45% of its portfolio.

Since February 1, 2017, it had 0 buys, and 5 sales for $14.98 million activity. Oak Assocs Oh holds 0.25% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 21,700 shares. Shares for $1.78 million were sold by Kapusta Ronald A. $2.45 million worth of stock was sold by Ullmann Michael H on Wednesday, February 1. RGT Capital Management Ltd. purchased a new position in Johnson & Johnson during the third quarter valued at approximately $1,236,000.

Investors sentiment increased to 1.14 in 2016 Q4. Shares for $79,066 were sold by Collins Tomago. The company was maintained on Friday, June 23 by RBC Capital Markets. Professional Advisory Services reported 0.06% stake. Trust Of Toledo Na Oh stated it has 31,022 shares or 1% of all its holdings. Lenox Wealth Advisors Inc. raised its position in shares of Johnson & Johnson by 0.7% in the first quarter. Sterling Capital Management Lc holds 93,902 shares or 0.11% of its portfolio. Bartlett & Limited Co holds 600 shares or 0% of its portfolio. Seabridge Advisors invested in 16,451 shares. Roffman Miller Associate Inc Pa reported 190,263 shares or 3.31% of all its holdings. Btim owns 17,989 shares. Glovista Invests Limited Liability, a New Jersey-based fund reported 5,960 shares. Alexandria Limited Liability Corporation reported 0.25% in Johnson & Johnson (NYSE:JNJ). 71,191 were reported by Provise Management Grp Ltd Llc.

Among 45 analysts covering Apple Inc. (NYSE:HD), 15 have Buy rating, 0 Sell and 8 Hold. MasTec had 18 analyst reports since August 3, 2015 according to SRatingsIntel. The firm earned "Buy" rating on Thursday, September 24 by Beaufort Securities. RBC Capital Markets has "Outperform" rating and $133 target. The firm has "Buy" rating given on Thursday, April 13 by SunTrust.

Many investment firms and many large funds have purchased or sold their holdings of The corporation.